CLSDQ · Clearside Biomedical, Inc.
$0.25
+0.00 (+0.00%)
At close · Jul 22
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current plans and forecasted expenses and our cash and cash equivalents, we do not believe we will be able to fund our operations for the next 12 months from the date of this filing. These factors raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$1.30M
Shares
5.23M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-06-30 | 95,698 | 95,698 | 0 | 18.07 |
| 2026-06-15 | 95,698 | 95,794 | -96 | 8.50 |
| 2026-05-29 | 95,794 | 107,196 | -11,402 | 7.66 |
| 2026-05-15 | 107,196 | 110,633 | -3,437 | 23.09 |
| 2026-04-30 | 110,633 | 83,291 | +27,342 | 1.59 |
| 2026-04-15 | 83,291 | 83,291 | 0 | 1.45 |
| 2026-03-31 | 83,291 | 81,392 | +1,899 | 1.32 |
| 2026-03-13 | 81,392 | 75,468 | +5,924 | 4.60 |
| 2026-02-27 | 75,468 | 68,923 | +6,545 | 2.58 |
| 2026-02-13 | 68,923 | 52,901 | +16,022 | 1.61 |
| 2026-01-30 | 52,901 | 9,693 | +43,208 | 1.00 |
| 2026-01-15 | 9,693 | 23,990 | -14,297 | 1.00 |
| 2025-12-31 | 23,990 | 67,452 | -43,462 | 1.00 |
| 2025-12-15 | 67,452 | 757,199 | -689,747 | 1.00 |
Showing 1–14 of 14 settlements